The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave

Background: Due to the unclear protective role of produced antibodies and the need for seroepidemiologic studies, we surveyed the COVID-19 seroprevalence among healthcare professionals who had direct or indirect contact with COVID-19 patients. Methods: From 19 October 2020 to 17 February 2021, 300 healthcare workers were enrolled and tested for serum antibodies in this prospective cohort study. Demographic information, risk factors, and infection history were collected. Anti- SARS-CoV-2 IgG and IgM antibody titers were determined to estimate the seroconversion rate. Results: During the first and second phases of the study, the positive seroconversion rates were 31.7 and 26.6%, respectively. In seronegative individuals, sixteen (10.6%) new cases of COVID-19 and five (6.3%) reinfections were identified. Among those with a positive antibody level, forty-one (36.9%) healthcare workers reported no symptoms in the preceding months. There was no association between occupational exposure and an increased probability of seroconversion. Conclusions: The seropositivity rate and the rate of asymptomatic individuals with seroconversion was remarkable and could be an indicator of a high infection rate among healthcare workers.

[1]  D. Skowronski,et al.  Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA–Vaccinated and Nonvaccinated Individuals in Quebec, Canada , 2022, JAMA network open.

[2]  M. Fonseca,et al.  Persistently positive SARS‐CoV‐2‐specific IgM during 1‐year follow‐up , 2022, Journal of medical virology.

[3]  R. Balicer,et al.  Comparing COVID-19-related hospitalization rates among individuals with infection-induced and vaccine-induced immunity in Israel , 2022, Nature Communications.

[4]  Mohamad Hamad Ba Al-Naemi,et al.  Life span of Covid-19 antibodies following infection in a sample worker population in Qatar , 2021, Journal of Emergency Medicine, Trauma and Acute Care.

[5]  Shaghayegh Haghjooy Javanmard,et al.  Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran , 2021, Future Virology.

[6]  Haiyan Wang,et al.  Early Viral Clearance and Antibody Kinetics of COVID-19 Among Asymptomatic Carriers , 2020, Frontiers in Medicine.

[7]  Shaghayegh Haghjooy Javanmard,et al.  SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study , 2020, The Lancet Infectious Diseases.

[8]  J. Eriksson,et al.  Low rate of COVID-19 seroconversion in health-care workers at a Department of Infectious Diseases in Sweden during the later phase of the first wave; a prospective longitudinal seroepidemiological study , 2020, Infectious diseases.

[9]  R. Homayouni,et al.  COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  A. Kenarkoohi,et al.  COVID-19 reinfection: prolonged shedding or true reinfection? , 2020, New Microbes and New Infections.

[11]  G. Maine,et al.  Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect , 2020, Journal of Clinical Virology.

[12]  H. Tegel,et al.  SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden , 2020, Nature Communications.

[13]  P. Kremsner,et al.  Asymptomatic SARS Coronavirus 2 infection: Invisible yet invincible , 2020, International Journal of Infectious Diseases.

[14]  M. Jorge Cardoso,et al.  Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study , 2020, The Lancet Public Health.

[15]  C. Colosio,et al.  SARS-CoV-2 specific serological pattern in healthcare workers of an Italian COVID-19 forefront hospital , 2020, BMC Pulmonary Medicine.

[16]  Robert L. Goldstone,et al.  Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers , 2020, The Lancet.

[17]  Melis N. Anahtar,et al.  Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital , 2020, medRxiv.

[18]  X. Tang,et al.  Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections , 2020, Nature Medicine.

[19]  P. Vermeersch,et al.  Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium. , 2020, JAMA.

[20]  Eric J Topol,et al.  Prevalence of Asymptomatic SARS-CoV-2 Infection , 2020, Annals of Internal Medicine.

[21]  D. R. Mendu,et al.  Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers at a Tertiary Academic Hospital in New York City , 2020, Journal of General Internal Medicine.

[22]  Robert Kubina,et al.  Molecular and Serological Tests for COVID-19. A Comparative Review of SARS-CoV-2 Coronavirus Laboratory and Point-of-Care Diagnostics , 2020, Diagnostics.

[23]  Sayak Roy.  COVID-19 Reinfection: Myth or Truth? , 2020, SN Comprehensive Clinical Medicine.

[24]  A. Kribben,et al.  SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients , 2020, Journal of Clinical Virology.

[25]  Chuan Qin,et al.  Coronavirus Disease 2019 (COVID-2019) Infection Among Health Care Workers and Implications for Prevention Measures in a Tertiary Hospital in Wuhan, China , 2020, JAMA network open.

[26]  Anne Kimball,et al.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.

[27]  P. Kellam,et al.  The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection , 2020, The Journal of general virology.

[28]  Panos Toulis.  Estimation of Covid-19 prevalence from serology tests: A partial identification approach , 2020, Journal of Econometrics.

[29]  Xingxia Yu,et al.  COVID‐19 transmission through asymptomatic carriers is a challenge to containment , 2020, Influenza and other respiratory viruses.

[30]  Beng Hoong Poon,et al.  COVID-19 and the Risk to Health Care Workers: A Case Report , 2020, Annals of Internal Medicine.

[31]  Yunbao Pan,et al.  Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation , 2020, Journal of Infection.

[32]  G. Winslow,et al.  IgM in microbial infections: taken for granted? , 2009, Immunology letters.

[33]  R. V. Krejcie,et al.  Determining Sample Size for Research Activities , 1970 .